Stocks to buy in 2026 for long term: Nippon Life, Gravita India among 5 stocks that could give double digit returns – Brokerage Recommendations – News Air Insight

Spread the love



JM Financial on Corona Remedies: Initiate Coverage| Buy| Target Rs 1866| LTP Rs 1582| Potential Upside 18%

JM Financial has also initiated coverage on Corona Remedies with a Buy rating, assigning a target price of Rs 1,866. With the stock currently trading at Rs 1,582, the brokerage expects a potential upside of about 18%.

(Disclaimer: Recommendations, suggestions, views, and opinions given by experts are their own. These do not represent the views of the Economic Times)



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *